ASIA — Asia Green Biotechnology Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Asia Green Biotechnology, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.767 | 0.553 | 0.523 | 0.145 | 0.191 |
| Operating Profit | -0.767 | -0.553 | -0.523 | -0.145 | -0.191 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.767 | -0.553 | -0.525 | -0.164 | -0.221 |
| Net Income After Taxes | -0.767 | -0.553 | -0.525 | -0.164 | -0.221 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.767 | -0.553 | -0.525 | -0.164 | -0.221 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.767 | -0.553 | -0.525 | -0.164 | -0.221 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.031 | -0.02 | -0.016 | -0.005 | -0.006 |